229 related articles for article (PubMed ID: 31914696)
1. Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence.
Pirozzi C; Lama A; Annunziata C; Cavaliere G; De Caro C; Citraro R; Russo E; Tallarico M; Iannone M; Ferrante MC; Mollica MP; Mattace Raso G; De Sarro G; Calignano A; Meli R
FASEB J; 2020 Jan; 34(1):676-690. PubMed ID: 31914696
[TBL] [Abstract][Full Text] [Related]
2. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model.
Komulainen T; Lodge T; Hinttala R; Bolszak M; Pietilä M; Koivunen P; Hakkola J; Poulton J; Morten KJ; Uusimaa J
Toxicology; 2015 May; 331():47-56. PubMed ID: 25745980
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid induced liver injury: An insight into molecular toxicological mechanism.
Ezhilarasan D; Mani U
Environ Toxicol Pharmacol; 2022 Oct; 95():103967. PubMed ID: 36058508
[TBL] [Abstract][Full Text] [Related]
4. Melatonin ameliorates sodium valproate-induced hepatotoxicity in rats.
Oztopuz O; Turkon H; Buyuk B; Coskun O; Sehitoglu MH; Ovali MA; Uzun M
Mol Biol Rep; 2020 Jan; 47(1):317-325. PubMed ID: 31624995
[TBL] [Abstract][Full Text] [Related]
5. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro; impact of C/EBPα-controlled gene expression.
Caiment F; Wolters J; Smit E; Schrooders Y; Kleinjans J; van den Beucken T
Arch Toxicol; 2020 Oct; 94(10):3463-3473. PubMed ID: 32623605
[TBL] [Abstract][Full Text] [Related]
7. Carnitine in the treatment of valproic acid-induced toxicity.
Lheureux PE; Hantson P
Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans.
Goda K; Kobayashi A; Takahashi A; Takahashi T; Saito K; Maekawa K; Saito Y; Sugai S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417920
[TBL] [Abstract][Full Text] [Related]
9. Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice.
Johnson J; Pajarillo EAB; Taka E; Reams R; Son DS; Aschner M; Lee E
Neurotoxicology; 2018 Jan; 64():230-239. PubMed ID: 28610743
[TBL] [Abstract][Full Text] [Related]
10. Sodium Propionate or Sodium Butyrate Promotes Fatty Acid Oxidation in HepG2 Cells Under Oxidative Stress.
Cook KJ; Coulter A; Keenan M; Greenway F; Losso JN
J Med Food; 2023 Jan; 26(1):74-79. PubMed ID: 36637439
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes.
Tong V; Teng XW; Chang TK; Abbott FS
Toxicol Sci; 2005 Aug; 86(2):436-43. PubMed ID: 15858222
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of valproic acid-induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney.
Heidari R; Jafari F; Khodaei F; Shirazi Yeganeh B; Niknahad H
Nephrology (Carlton); 2018 Apr; 23(4):351-361. PubMed ID: 28141910
[TBL] [Abstract][Full Text] [Related]
13. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.
Rodrigues RM; Branson S; De Boe V; Sachinidis A; Rogiers V; De Kock J; Vanhaecke T
Arch Toxicol; 2016 Mar; 90(3):677-89. PubMed ID: 25716160
[TBL] [Abstract][Full Text] [Related]
14. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.
Silva MF; Aires CC; Luis PB; Ruiter JP; IJlst L; Duran M; Wanders RJ; Tavares de Almeida I
J Inherit Metab Dis; 2008 Apr; 31(2):205-16. PubMed ID: 18392741
[TBL] [Abstract][Full Text] [Related]
16. Benzbromarone aggravates hepatic steatosis in obese individuals.
Sun P; Zhu JJ; Wang T; Huang Q; Zhou YR; Yu BW; Jiang HL; Wang HY
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2067-2077. PubMed ID: 29526820
[TBL] [Abstract][Full Text] [Related]
17. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis.
Pourahmad J; Eskandari MR; Kaghazi A; Shaki F; Shahraki J; Fard JK
Toxicol In Vitro; 2012 Jun; 26(4):545-51. PubMed ID: 22342442
[TBL] [Abstract][Full Text] [Related]
18. Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen.
Abdel-Dayem MA; Elmarakby AA; Abdel-Aziz AA; Pye C; Said SA; El-Mowafy AM
Drugs R D; 2014 Jun; 14(2):85-94. PubMed ID: 24733439
[TBL] [Abstract][Full Text] [Related]
19. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting.
Löscher W; Wahnschaffe U; Hönack D; Drews E; Nau H
Epilepsy Res; 1993 Dec; 16(3):183-94. PubMed ID: 8119269
[TBL] [Abstract][Full Text] [Related]
20. Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activation.
Kumar KJ; Chu FH; Hsieh HW; Liao JW; Li WH; Lin JC; Shaw JF; Wang SY
J Ethnopharmacol; 2011 Jun; 136(1):168-77. PubMed ID: 21540101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
